We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+8.27%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$301B
AUM Growth
+$28B
Cap. Flow
+$8.83B
Cap. Flow %
2.93%
Top 10 Hldgs %
16.6%
Holding
3,648
New
163
Increased
2,481
Reduced
676
Closed
240

Sector Composition

Rank Sector Weight
1 Technology 20.17%
2 Financials 13.07%
3 Healthcare 12.05%
4 Consumer Discretionary 10.98%
5 Industrials 9.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTOO
3351
DELISTED
T2 Biosystems, Inc
TTOO
$57K ﹤0.01%
10
ABEO icon
3352
Abeona Therapeutics
ABEO
$355M
$56K ﹤0.01%
1,411
-5,141
-78% -$210K
GALT icon
3353
Galectin Therapeutics
GALT
$230M
$56K ﹤0.01%
17,413
-60,075
-78% -$214K
XWEL icon
3354
XWELL
XWEL
$8.95M
$56K ﹤0.01%
1,814
LODE icon
3355
Comstock
LODE
$206M
$55K ﹤0.01%
1,498
-1,507
-50% -$58.1K
MARK
3356
DELISTED
Remark Holdings, Inc.
MARK
$55K ﹤0.01%
2,905
SIOX
3357
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$55K ﹤0.01%
+20,023
New +$49.8K
TYME
3358
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$55K ﹤0.01%
42,998
-153,809
-78% -$222K
PHLT
3359
DELISTED
Performant Healthcare Inc
PHLT
$54K ﹤0.01%
+14,263
New +$40.6K
XCUR icon
3360
Exicure
XCUR
$11M
$53K ﹤0.01%
234
-869
-79% -$228K
LPCN icon
3361
Lipocine
LPCN
$17.1M
$52K ﹤0.01%
2,153
OPGN
3362
DELISTED
OpGen, Inc
OPGN
$52K ﹤0.01%
+113
New +$51.7K
RESN
3363
DELISTED
Resonant Inc.
RESN
$52K ﹤0.01%
15,910
-105,928
-87% -$364K
VISL
3364
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$52K ﹤0.01%
899
CDTX
3365
DELISTED
Cidara Therapeutics
CDTX
$51K ﹤0.01%
1,250
-2,503
-67% -$106K
VNRX icon
3366
VolitionRx Ltd
VNRX
$9.31M
$51K ﹤0.01%
769
-3,248
-81% -$220K
AGTC
3367
DELISTED
Applied Genetic Technologies Corporation
AGTC
$51K ﹤0.01%
12,820
-91,310
-88% -$379K
CKPT
3368
DELISTED
Checkpoint Therapeutics
CKPT
$50K ﹤0.01%
1,694
-10,796
-86% -$299K
COCP icon
3369
Cocrystal Pharma
COCP
$12M
$50K ﹤0.01%
+3,270
New +$49.7K
APTX
3370
DELISTED
Aptinyx Inc. Common Stock
APTX
$50K ﹤0.01%
17,590
-71,316
-80% -$199K
REED
3371
DELISTED
Reeds, Inc. Common Stock
REED
$50K ﹤0.01%
+962
New +$49.4K
CTIC
3372
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$50K ﹤0.01%
20,000
AMPY icon
3373
Amplify Energy
AMPY
$158M
$49K ﹤0.01%
11,998
HDSN
3374
Hudson Technologies
HDSN
$246M
$49K ﹤0.01%
14,328
IZEA icon
3375
IZEA Worldwide
IZEA
$58.7M
$49K ﹤0.01%
4,753

Similar funds

Charles Schwab's Q2 2021 Portfolio in Review

As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
  • Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
  • Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
  • Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
  • Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
  • Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
  • Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.

Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.